All articles by cmsadmin 

  1. European over-prescribing becoming “chronic”

    The over-prescription of medicines in Europe, particularly for the elderly, is becoming chronic, according to a study conducted by Salzburg…
    Read More…

    19 Sep
  2. NICE recommends AstraZeneca’s Brilique

    A UK health watchdog has recommended AstraZeneca drug Brilique (ticagrelor) for the treatment of acute coronary syndromes caused by blood…
    Read More…

    19 Sep
  3. KAI partners Ono to develop KAI-4169

    KAI Pharmaceuticals has entered into an agreement with Ono Pharmaceutical for the development and commercialisation of KAI-4169 in Japan. KAI-4169,…
    Read More…

    19 Sep
  4. Teva signs antiviral drug development agreement with Cocrystal Discovery

    Teva Pharmaceutical Industries has signed a license and share purchase agreement with Cocrystal Discovery, a biopharmaceutical company focused on the…
    Read More…

    19 Sep
  5. Trial and error: site selection for clinical studies

    Getting the right results from a clinical trial starts with choosing the right site as its success is determined by…
    Read More…

    19 Sep
  6. AB Science receives FDA approval to commence asthma drug study

    AB Science has obtained investigational new drug status from the US Food and Drug Administration (FDA), allowing it to commence…
    Read More…

    18 Sep
  7. ConjuChem commences diabetes drug trial

    ConjuChem has initiated patient enrolment in a Phase II clinical trial of its proprietary GLP-1 receptor agonist drug CJC-1134-PC in…
    Read More…

    18 Sep
  8. FDA launches investigation into GlaxoSmithKline’s Zofran

    The US Food and Drug Administration (FDA) has launched an investigation into GlaxoSmithKline’s Zofran medication, used to treat nausea, following…
    Read More…

    18 Sep
  9. Bachmann comments over HPV vaccine are dangerous, say US doctors

    Doctors in the US are expecting more parents to refuse Merck’s human papilloma virus (HPV) vaccine, after presidential candidate Michele…
    Read More…

    15 Sep
  10. Pfizer yet to make divestment decisions

    Pfizer has yet to make a definitive decision over its non-core businesses, contradicting previous reports that indicated its nutritionals division…
    Read More…

    15 Sep
Close
Close
Close

Go Top